Alembic Pharmaceuticals Receives USFDA EIR for Karakhadi API-III Facility

19 May, 2025, Bengaluru: Alembic Pharmaceuticals Limited has received the Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for its API-III manufacturing facility located at Karakhadi, Gujarat.

The inspection was conducted from 17th March, 2025 to 21st March, 2025.

Check Also

Tata Steel’s Hooghly Met Coke in Haldia Becomes First Non-Recovery Coke Maker in India to Cross 25 Million Tonne Milestone

~ Sets a new national benchmark in metallurgical coke production without major overhaul ~ Chandigarh, …